118,780 Shares in Acadia Healthcare Company, Inc. $ACHC Bought by Cibc World Market Inc.

Cibc World Market Inc. acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 118,780 shares of the company’s stock, valued at approximately $3,508,000. Cibc World Market Inc. owned approximately 0.13% of Acadia Healthcare as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. EverSource Wealth Advisors LLC lifted its stake in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares in the last quarter. Allworth Financial LP purchased a new stake in Acadia Healthcare during the 2nd quarter worth approximately $45,000. Wells Fargo & Company MN raised its holdings in shares of Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares during the last quarter. Global Retirement Partners LLC acquired a new stake in shares of Acadia Healthcare in the second quarter worth approximately $68,000. Finally, Quantbot Technologies LP purchased a new stake in shares of Acadia Healthcare during the second quarter worth approximately $88,000.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on ACHC. KeyCorp lifted their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Royal Bank Of Canada lifted their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. TD Cowen boosted their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Finally, Barclays increased their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $29.85.

Acadia Healthcare Price Performance

ACHC stock opened at $30.58 on Thursday. The business’s fifty day moving average price is $30.28 and its 200 day moving average price is $25.93. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $35.83. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The company has a market capitalization of $2.85 billion, a PE ratio of -2.46, a P/E/G ratio of 9.62 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.Acadia Healthcare’s revenue for the quarter was down .4% on a year-over-year basis. During the same period last year, the business posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.